| scholarly article | Q13442814 |
| P2093 | author name string | Bernet MF | |
| Servin AL | |||
| Brassart D | |||
| Neeser JR | |||
| P2860 | cites work | Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole | Q24646749 |
| Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells | Q28290485 | ||
| One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23 | Q28294341 | ||
| A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children | Q28302728 | ||
| Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli | Q34090631 | ||
| Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells | Q34173409 | ||
| Is there a role for lactobacilli in prevention of urogenital and intestinal infections? | Q34635146 | ||
| Travelers' diarrhea. Prevention and treatment | Q35398962 | ||
| The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures | Q35651713 | ||
| The interaction of bacteria with mammalian cells | Q35651739 | ||
| Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture | Q35960689 | ||
| Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells | Q36180586 | ||
| Expression of receptors for enterotoxigenic Escherichia coli during enterocytic differentiation of human polarized intestinal epithelial cells in culture | Q36946825 | ||
| New adhesive factor (antigen 8786) on a human enterotoxigenic Escherichia coli O117:H4 strain isolated in Africa | Q36962054 | ||
| Adhesion of enterotoxigenic Escherichia coli to the human colon carcinoma cell line Caco-2 in culture | Q36979183 | ||
| Use of purified F1845 fimbrial adhesin to study localization and expression of receptors for diffusely adhering Escherichia coli during enterocytic differentiation of human colon carcinoma cell lines HT-29 and Caco-2 in culture | Q36988911 | ||
| Adhesion of colonization factor antigen II-positive enterotoxigenic Escherichia coli strains to human enterocytelike differentiated HT-29 cells: a basis for host-pathogen interactions in the gut | Q37006869 | ||
| In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. | Q37008213 | ||
| Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells | Q40106221 | ||
| Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells | Q41610093 | ||
| Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus | Q41634513 | ||
| Characterization of interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells in vitro | Q41664000 | ||
| Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk | Q41681597 | ||
| Salmonella interactions with polarized human intestinal Caco-2 epithelial cells | Q41715988 | ||
| Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. | Q41719523 | ||
| Protein-mediated adhesion of Lactobacillus fermentum strain 737 to mouse stomach squamous epithelium | Q43477330 | ||
| In Vivo Effect of Yogurt on Excretion of Enteropathogen Escherichia coli RDEC-1 During Acute Diarrhea in the Just-Weaned Rabbit | Q45797580 | ||
| Survival of Lactobacillus species (strain GG) in human gastrointestinal tract | Q46653370 | ||
| Diffuse-adhering Escherichia coli (DAEC) as a putative cause of diarrhea in Mayan children in Mexico. | Q54699799 | ||
| Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract | Q69069224 | ||
| Adherence of Lactobacillus species to human fetal intestinal cells | Q70544225 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bacteria | Q10876 |
| Lactobacillus acidophilus | Q132644 | ||
| P304 | page(s) | 483-489 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria | |
| P478 | volume | 35 |
| Q35082219 | "Multivalent" saccharides: development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens |
| Q46611063 | 13C- and 15N-incorporation of doubly stable isotope labelled Lactobacillus johnsonii in humans |
| Q33305636 | 2-DE and MS analysis of interactions between Lactobacillus fermentum I5007 and intestinal epithelial cells |
| Q33894653 | 3-D intestinal scaffolds for evaluating the therapeutic potential of probiotics |
| Q58692702 | A Review on Some Chemical Engineering and Microbiological Aspects Considered in the Production of Highly Concentrated Probiotic Cultures and Bacteriocins by Lactococci and Lactobacilli |
| Q28379073 | A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29 |
| Q90724863 | A novel probiotic, Lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period |
| Q38143713 | A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action |
| Q35595192 | A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients |
| Q30891703 | A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms |
| Q33590786 | A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients |
| Q33987729 | A strain of Enterococcus faecium (18C23) inhibits adhesion of enterotoxigenic Escherichia coli K88 to porcine small intestine mucus |
| Q39625767 | Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes |
| Q36904890 | Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy |
| Q37260988 | Adherence, anti-adherence, and oligosaccharides preventing pathogens from sticking to the host |
| Q39549987 | Adherent properties and macrophage activation ability of 3 strains of lactic acid bacteria |
| Q57817517 | Adhesion Properties of Food-Associated Strains on Human Intestinal Epithelial Cells and Modulation of IL-8 Release |
| Q33844207 | Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407. |
| Q41328596 | Adhesion of Lactobacilli and their anti-infectivity potential |
| Q35542616 | Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens |
| Q34472246 | Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures |
| Q63242460 | Adhesion studies for probiotics: need for validation and refinement |
| Q57110987 | Antagonistic Activities and Probiotic Potential of Lactic Acid Bacteria Derived From a Plant-Based Fermented Food |
| Q39425803 | Antagonistic activities of lactobacilli against Helicobacter pylori growth and infection in human gastric epithelial cells |
| Q35890738 | Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens |
| Q33719312 | Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB |
| Q34737893 | Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection |
| Q43910008 | Antagonistic activity of Lactobacillus casei strain shirota against gastrointestinal Listeria monocytogenes infection in rats |
| Q92056883 | Antagonistic and antioxidant effect of probiotic Weissella cibaria JW15 |
| Q50121631 | Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice. |
| Q55279327 | Antagonistic effect of isolated probiotic bacteria from natural sources against intestinal Escherichia coli pathotypes. |
| Q37712802 | Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents |
| Q35136011 | Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB |
| Q41046581 | Arabinoxylans, inulin and Lactobacillus reuteri 1063 repress the adherent-invasive Escherichia coli from mucus in a mucosa-comprising gut model |
| Q31775411 | Assay of D-lactate in urine of infants and children with reference values taking into account data below detection limit |
| Q31043982 | Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells |
| Q36403325 | Bacteria and the gastrointestinal tract: beneficial and harmful effects |
| Q56210264 | Bacteriocin production by strain Lactobacillus delbrueckii ssp. bulgaricus BB18 during continuous prefermentation of yogurt starter culture and subsequent batch coagulation of milk |
| Q38245868 | Basic and clinical research on the regulation of the intestinal barrier by Lactobacillus and its active protein components: a review with experience of one center |
| Q35542612 | Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. |
| Q38025737 | Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens |
| Q26744578 | Bifidobacteria and Their Role as Members of the Human Gut Microbiota |
| Q35361878 | Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity |
| Q60920995 | Biological Activities of Lactose-Based Prebiotics and Symbiosis with Probiotics on Controlling Osteoporosis, Blood-Lipid and Glucose Levels |
| Q57825805 | Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System |
| Q38254327 | Biological pathways involved in the development of inflammatory bowel disease |
| Q91908911 | CASE STUDY: Effects of a blend of prebiotics, probiotics, and hyperimmune dried egg protein on the performance, health, and innate immune responses of Holstein calves |
| Q33623573 | Capsular polysaccharide inhibits adhesion of Bifidobacterium longum 105-A to enterocyte-like Caco-2 cells and phagocytosis by macrophages |
| Q28910480 | Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins |
| Q39480805 | Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells |
| Q21131205 | Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics |
| Q35879383 | Characterization of a novel bile-inducible operon encoding a two-component regulatory system in Lactobacillus acidophilus |
| Q40924251 | Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges |
| Q64077155 | Clostridium difficile Modulates the Gut Microbiota by Inducing the Production of Indole, an Interkingdom Signaling and Antimicrobial Molecule |
| Q35891817 | Community-based interference against integration of Pseudomonas aeruginosa into human salivary microbial biofilm |
| Q33788040 | Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice pretreated with streptomycin |
| Q36757913 | Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species |
| Q36517851 | Competition of Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells |
| Q37871423 | Current trends in critical care nutrition |
| Q39527762 | D-Lactate dehydrogenase gene (ldhD) inactivation and resulting metabolic effects in the Lactobacillus johnsonii strains La1 and N312. |
| Q26991504 | Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent |
| Q83121425 | Different effects of probiotic species/strains on infections in preschool children: A double-blind, randomized, controlled study |
| Q30422767 | Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States |
| Q34522706 | Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro |
| Q83558950 | Dramatic changes of the gut flora immediately after severe and sudden insults |
| Q34359414 | Dynamic alteration of the colonic microbiota in intestinal ischemia-reperfusion injury |
| Q35348967 | Ecological control of the gastrointestinal tract. The role of probiotic flora |
| Q44129096 | Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis |
| Q73565856 | Effect of Lactobacillus-fermented diets on bacterial translocation and intestinal flora in experimental prehepatic portal hypertension |
| Q49960932 | Effect of Propionibacterium freudenreichii on Salmonella multiplication, motility, and association with avian epithelial cells1. |
| Q39640427 | Effect of Weissella confusa strain PL9001 on the adherence and growth of Helicobacter pylori |
| Q59391274 | Effect of bacteriocin-producing lactobacilli on the survival of Escherichia coli and Listeria in a dynamic model of the stomach and the small intestine |
| Q50098057 | Effect of the Escherichia coli EMO strain on experimental infection by Salmonella enterica serovar Typhimurium in gnotobiotic mice |
| Q110697577 | Eimeria pragensis infection alters the gut microenvironment to favor extrinsic shiga toxin-producing Escherichia coli O157:H7 colonization in mice |
| Q37424510 | Enterococcus faecium HDRsEf1 Protects the Intestinal Epithelium and Attenuates ETEC-Induced IL-8 Secretion in Enterocytes. |
| Q47129733 | Epithelial Barrier Function in Gut-Bone Signaling. |
| Q24669669 | Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection |
| Q39650119 | Evaluation of in vitro Probiotic Potential of Pediococcus pentosaceus OZF Isolated from Human Breast Milk |
| Q34403872 | Food processing: probiotic microorganisms for beneficial foods |
| Q36812238 | Functional Analysis of an S-Layer-Associated Fibronectin-Binding Protein in Lactobacillus acidophilus NCFM |
| Q38317978 | Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. |
| Q50025602 | Functional properties of free and encapsulated Lactobacillus reuteri DPC16 during and after passage through a simulated gastrointestinal tract |
| Q33744907 | Functionality of probiotics and intestinal lactobacilli: light in the intestinal tract tunnel |
| Q37118457 | Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients |
| Q34293646 | Genome sequence of Lactobacillus mucosae LM1, isolated from piglet feces |
| Q28209082 | Gut flora in health and disease |
| Q34401547 | H(2)O(2) production in species of the Lactobacillus acidophilus group: a central role for a novel NADH-dependent flavin reductase |
| Q35549642 | H. pylori and its modulation of gastrointestinal microbiota |
| Q37969590 | Helicobacter pylori and other gastric bacteria |
| Q37273581 | High Iron-Sequestrating Bifidobacteria Inhibit Enteropathogen Growth and Adhesion to Intestinal Epithelial Cells In vitro |
| Q43815680 | Histological examination of non-lactating bovine udders inoculated with Lactobacillus perolens CRL 1724. |
| Q33886266 | Host specific diversity in Lactobacillus johnsonii as evidenced by a major chromosomal inversion and phage resistance mechanisms |
| Q96306955 | Human microbiome: an academic update on human body site specific surveillance and its possible role |
| Q35919120 | Identification of Lactobacillus proteins with different recognition patterns between immune rabbit sera and nonimmune mice or human sera |
| Q30802251 | Imaging of lactic acid bacteria with AFM--elasticity and adhesion maps and their relationship to biological and structural data |
| Q63916146 | Immunology of pre- and probiotic supplementation |
| Q74822286 | Immunonutrition: role of biosurfactants, fiber, and probiotic bacteria |
| Q37781315 | Importance of disrupted intestinal barrier in inflammatory bowel diseases |
| Q80583593 | Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533) |
| Q43332026 | Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1. |
| Q31004513 | In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli |
| Q40862239 | In vitro antagonistic activity of Lactobacillus casei against Helicobacter pylori. |
| Q41807252 | In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli |
| Q46896627 | In vitro evaluation of the mucin-adhesion ability and probiotic potential of Lactobacillus mucosae LM1. |
| Q40360404 | In vitro inhibition of Helicobacter pylori by Enterococcus faecium GM-1. |
| Q36538779 | In vitro model of colonization resistance by the enteric microbiota: effects of antimicrobial agents used in food-producing animals |
| Q40716918 | Influence of fermentation medium composition on physicochemical surface properties of Lactobacillus acidophilus |
| Q33990613 | Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: an in vitro study |
| Q50114460 | Inhibition of adhesion of food-borne pathogens to Caco-2 cells by Lactobacillus strains |
| Q44373362 | Inhibitory effect of Lactobacillus acidophilus on Helicobacter hepaticus in vitro |
| Q36116248 | Intestinal Lactobacillus community structure and its correlation with diet of Southern Chinese elderly subjects |
| Q74708935 | Intestinal microbial patterns of the common marmoset and rhesus macaque |
| Q35867542 | Involvement of the mannose receptor and p38 mitogen-activated protein kinase signaling pathway of the microdomain of the integral membrane protein after enteropathogenic Escherichia coli infection |
| Q53629667 | Isolation and characterization of lactobacilli from human faeces and indigenous fermented foods for their potential application as probiotics. |
| Q50117292 | Isolation of human faecal bifidobacteria which reduce signs of Salmonella infection when orogastrically dosed to mice |
| Q39195348 | Lactic acid bacterial extracts as anti-Helicobacter pylori: a molecular approach. |
| Q33802282 | Lactobacillus GG for treatment of acute childhood diarrhoea: an open labelled, randomized controlled trial |
| Q36494674 | Lactobacillus acidophilus upregulates intestinal NHE3 expression and function |
| Q26827553 | Lactobacillus adhesion to mucus |
| Q40414006 | Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells |
| Q40997508 | Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo |
| Q35132967 | Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis |
| Q39489129 | Lactobacillus plantarum AS1 binds to cultured human intestinal cell line HT-29 and inhibits cell attachment by enterovirulent bacterium Vibrio parahaemolyticus |
| Q38684853 | Lactobacillus reuteri Inhibition of Enteropathogenic Escherichia coli Adherence to Human Intestinal Epithelium |
| Q59132881 | Linoleic Acids Overproducing Limits Growth, Survival, and Virulence of Typhimurium and Enterohaemorrhagic |
| Q35271563 | Modification of the technical properties of Lactobacillus johnsonii NCC 533 by supplementing the growth medium with unsaturated fatty acids |
| Q92402088 | Molecular Switch Controlling Expression of the Mannose-Specific Adhesin, Msa, in Lactobacillus plantarum |
| Q54105741 | Monoassociation with Lactobacillus acidophilus UFV-H2b20 stimulates the immune defense mechanisms of germfree mice. |
| Q35597617 | Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid |
| Q42018332 | Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures |
| Q77453617 | Nutritional management of acute diarrhea |
| Q50047711 | Oral administration of heat-killed Lactobacillus plantarum strain b240 protected mice against Salmonella enterica Serovar Typhimurium |
| Q77093898 | Overview of gut flora and probiotics |
| Q28486844 | Oxygen relieves the CO2 and acetate dependency of Lactobacillus johnsonii NCC 533 |
| Q38848225 | Potential role of probiotics in the management of gastric ulcer |
| Q24681377 | Potential uses of probiotics in clinical practice |
| Q36148926 | Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota |
| Q46866014 | Presence of two Lactobacillus and Bifidobacterium probiotic strains in the neonatal ileum. |
| Q42581179 | Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model |
| Q36800681 | Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs |
| Q64093383 | Probiotic Potential and Safety Evaluation of Enterococcus faecalis OB14 and OB15, Isolated From Traditional Tunisian Testouri Cheese and Rigouta, Using Physiological and Genomic Analysis |
| Q40810762 | Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties |
| Q24548482 | Probiotic bacteria as biological control agents in aquaculture |
| Q42954872 | Probiotic bacteria change Escherichia coli-induced gene expression in cultured colonocytes: Implications in intestinal pathophysiology |
| Q34133456 | Probiotic bacteria: safety, functional and technological properties |
| Q33554139 | Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells |
| Q39424544 | Probiotic properties of Lactobacillus plantarum CECT 7315 and CECT 7316 isolated from faeces of healthy children. |
| Q34214512 | Probiotic therapy: immunomodulating approach toward urinary tract infection |
| Q39265808 | Probiotic treatment for the prevention of antibiotic-associated diarrhoea in geriatric patients: a multicentre randomised controlled pilot study |
| Q74404043 | Probiotics and Functional Foods in Gastrointestinal Disorders |
| Q35128668 | Probiotics and Inflammatory Bowel Disease |
| Q36160698 | Probiotics and barrier function in colitis |
| Q34317609 | Probiotics and functional foods in gastrointestinal disorders |
| Q34665535 | Probiotics and immune response. |
| Q83929578 | Probiotics and inflammatory bowel diseases |
| Q24524299 | Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? |
| Q81885279 | Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? |
| Q37292430 | Probiotics and small bowel mucosa: Molecular aspects of their interactions |
| Q38598371 | Probiotics and the Gut Immune System: Indirect Regulation |
| Q34820531 | Probiotics as modulators of the gut flora |
| Q24242963 | Probiotics for induction of remission in ulcerative colitis |
| Q24245074 | Probiotics for induction of remission in ulcerative colitis |
| Q26825005 | Probiotics for the treatment of Helicobacter pylori infection in children |
| Q34646254 | Probiotics in infectious diarrhoea in children: are they indicated? |
| Q92876444 | Probiotics in the next-generation sequencing era |
| Q41975206 | Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT29 cells. |
| Q35542621 | Probiotics to enhance anti-infective defences in the gastrointestinal tract |
| Q35744173 | Probiotics, prebiotics and child health: where are we going? |
| Q39389296 | Probiotics: Functionality and commercial status |
| Q37681016 | Probiotics: multifarious oral vaccine against infectious traumas |
| Q33941313 | Promotion of a favorable gut flora in inflammatory bowel disease |
| Q40600349 | Prophylactic feeding of Lactobacillus acidophilus NCFM to mice attenuates overt colonic hyperplasia |
| Q46968368 | Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis. |
| Q50127310 | Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. typhimurium in conventional and gnotobiotic mice. |
| Q34101848 | Protective effect of probiotics on Salmonella infectivity assessed with combined in vitro gut fermentation-cellular models |
| Q33916000 | Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria |
| Q35598284 | Randomised clinical trial of synbiotic therapy in elective surgical patients |
| Q26746001 | Recent Advances in Screening of Anti-Campylobacter Activity in Probiotics for Use in Poultry |
| Q47695159 | Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit |
| Q40840258 | Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease |
| Q34207425 | Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis |
| Q37058869 | Role of the intestinal barrier in inflammatory bowel disease |
| Q39210407 | Roles of Probiotic Lactobacilli Inclusion in Helping Piglets Establish Healthy Intestinal Inter-environment for Pathogen Defense |
| Q37355090 | Saccharomyces boulardii in childhood |
| Q57717240 | Safety of probiotics |
| Q47152214 | Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus acidophilus BCCM/LMG P-18806, Lactobacillus delbrueckii BCCM/LMG P-18805 and Streptococcus thermophilus BCCM/LMG P-18807 and reduction of gastro-in... |
| Q50067761 | Screening from pickled vegetables the potential probiotic strains of lactic acid bacteria able to inhibit the Salmonella invasion in mice |
| Q39483772 | Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. |
| Q24651518 | Skin microbiota: a source of disease or defence? |
| Q50030181 | Strain dependent protection conferred by Lactobacillus spp. administered orally with a Salmonella Typhimurium vaccine in a murine challenge model. |
| Q37722831 | Surface and adhesion properties of lactobacilli |
| Q73995346 | Surface characterization and adhesive properties of bifidobacteria |
| Q44914227 | Survival of Enterobacter cloacae and Pseudomonas paucimobilis in yoghurts manufactured from cow's milk and soymilk during storage at different temperatures |
| Q34520863 | Synthetic small intestinal scaffolds for improved studies of intestinal differentiation. |
| Q85122657 | The Microbiota and infectious diarrhea |
| Q40264779 | The cell wall of lactic acid bacteria: surface constituents and macromolecular conformations |
| Q50040118 | The effects of fermented milk containing Lactococcus lactis subsp. cremoris FC on defaecation in healthy young Japanese women: a double-blind, placebo-controlled study |
| Q34647328 | The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota |
| Q22066391 | The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533 |
| Q37848454 | The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept |
| Q35229546 | The hsp 16 gene of the probiotic Lactobacillus acidophilus is differently regulated by salt, high temperature and acidic stresses, as revealed by reverse transcription quantitative PCR (qRT-PCR) analysis |
| Q35202986 | The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo |
| Q38008242 | The interactions between endogenous bacteria, dietary components and the mucus layer of the large bowel. |
| Q42171396 | The metabolic fate of doubly stable isotope labelled heat-killed Lactobacillus johnsonii in humans |
| Q48226415 | The microbiota metabolite indole inhibits Salmonella virulence: Involvement of the PhoPQ two-component system |
| Q40574865 | The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens |
| Q24548346 | The scientific basis for probiotic strains of Lactobacillus |
| Q26823347 | The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts |
| Q36116450 | Use of probiotics in children with acute diarrhea |
| Q89885530 | Viability of microencapsulated and non-microencapsulated Lactobacilli in a commercial beverage |
| Q53478280 | [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)]. |
Search more.